Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The study found unique microscopic features for hair or feather in five animal ingredients in Shenrongbian pill.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Microneedling with platelet-rich plasma helps dog hair regrow faster than microneedling alone.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Artificial sebum L closely mimics human sebum for drug delivery research.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

The drug combination significantly reduced epileptic drop attacks in patients.